Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients With Focal Onset or Primary Generalized Tonic-Clonic Seizures

NCT06908356 is registered in ClinicalTrials.gov with Praxis Precision Medicines as lead sponsor.

NCT NCT06908356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06908356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients With Focal Onset or Primary Generalized Tonic-Clonic Seizures
Lead sponsor
Praxis Precision Medicines
Phase
Phase 2
Overall status
Recruiting
Start date
January 10, 2025
Completion date
July 31, 2025
Enrollment
50 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

focal onset seizure, primary generalized epilepsy